OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.27
-0.10 (-1.57%)
At close: Jul 30, 2026, 4:00 PM EDT
6.15
-0.12 (-1.91%)
After-hours: Jul 30, 2026, 4:46 PM EDT

OptimizeRx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
6.845.13-20.11-17.57-11.440.38
Depreciation & Amortization
4.34.334.332.42.021.97
Stock-Based Compensation
7.236.9611.4713.7215.755.49
Other Adjustments
1.291.488.539.760.360.08
Change in Receivables
0.730.46-2.17-8.712.28-6.99
Changes in Accounts Payable
-1.1-2.49-0.530.20.56-0.6
Changes in Accrued Expenses
-5.473.371.051.3-0.30.48
Changes in Income Taxes Payable
-0.76-1.07----
Changes in Unearned Revenue
0.160.030.3-0.07-1.231.1
Changes in Other Operating Activities
1.050.512.01-8.272.65-1.18
Operating Cash Flow
7.318.724.89-7.2410.650.73
Operating Cash Flow Growth
13.35%282.80%--1367.43%-
Capital Expenditures
-0.05-0.06-0.11-0.09-0.08-0.1
Sale of Property, Plant & Equipment
---0.01--
Purchases of Intangible Assets
-0.13-0.34-0.78-0.16-0.39
Purchases of Investments
----162.78-55.93-
Proceeds from Sale of Investments
---218.71--
Cash Acquisitions
----82.95-2-
Proceeds from Business Divestments
---2.54--
Investing Cash Flow
-0.080.07-0.45-25.34-58.18-0.49
Long-Term Debt Issued
---37.73--
Long-Term Debt Repaid
-10.19-8-4-1.71--
Net Long-Term Debt Issued (Repaid)
-10.19-8-436.02--
Issuance of Common Stock
-0.35--0.281.0775.54
Repurchase of Common Stock
-1.08-1.15-0.91-7.52-20.02-
Net Common Stock Issued (Repurchased)
-1.08-0.8-0.91-7.8-18.9575.54
Other Financing Activities
------1.61
Financing Cash Flow
-0.26-8.8-4.9128.22-18.9573.92
Net Cash Flow
3.69.99-0.47-4.36-66.4774.16
Free Cash Flow
7.2418.664.78-7.3310.570.63
Free Cash Flow Growth
14.44%290.56%--1589.75%-
FCF Margin
6.75%17.05%5.19%-10.24%16.93%1.02%
Free Cash Flow Per Share
0.380.980.26-0.430.590.04
Levered Free Cash Flow
-2.331.76-17.0513.93-7.822.05
Unlevered Free Cash Flow
3.4419.38-6.14-38.9-8.672.03
SEC Filings: 10-K · 10-Q